Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression
Titel:
Dasatinib (BMS-35482) Interacts Synergistically With Docetaxel, Gemcitabine, Topotecan, and Doxorubicin in Ovarian Cancer Cells With High SRC Pathway Activation and Protein Expression
Auteur:
Secord, Angeles Alvarez Teoh, Deanna Jia, Jingquan Nixon, Andrew B. Grace, Lisa Adams, David J. Murphy, Susan K.
Verschenen in:
International journal of gynecological cancer
Paginering:
Jaargang 24 () nr. 2 pagina's 218-225
Jaar:
2014
Inhoud:
Uitgever:
International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.